Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korea To Name Multi-billion Dollar Medical City In Effort To Draw More MNCs

This article was originally published in PharmAsia News

Executive Summary

SEOUL - South Korea's Ministry for Health, Welfare and Family Affairs will announce on August 10 the name of the city that won the government bid for the construction of a multi-billion dollar, high-tech medical center where multinational companies can link up with local pharma companies and medical community

You may also be interested in...



Korea's Budgetary Spending On Health Welfare Projects At All-Time High In 2010

SEOUL - South Korea's budgetary expenditure on health welfare projects is expected to rise 8.6 percent to KRW 81 trillion ($67.5 billion) next year, according to a proposal by the Ministry for Health, Welfare and Family Affairs submitted to the National Assembly for approval

Korea's Budgetary Spending On Health Welfare Projects At All-Time High In 2010

SEOUL - South Korea's budgetary expenditure on health welfare projects is expected to rise 8.6 percent to KRW 81 trillion ($67.5 billion) next year, according to a proposal by the Ministry for Health, Welfare and Family Affairs submitted to the National Assembly for approval

And The Winner Is? Two Cities For The Price Of One Win Bid For Multi-billion Dollar Korean Biopolis

SEOUL - South Korea's Ministry for Health, Welfare and Family Affairs named two cities - Osong and Daegu - as the winners of multi-billion-dollar, high-tech medical center sites planned in the country to draw multinational companies to the country

Related Content

UsernamePublicRestriction

Register

ID1130765

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel